bisoprolol has been researched along with Cardiomyopathy, Hypertrophic in 11 studies
Bisoprolol: A cardioselective beta-1 adrenergic blocker. It is effective in the management of HYPERTENSION and ANGINA PECTORIS.
Cardiomyopathy, Hypertrophic: A form of CARDIAC MUSCLE disease, characterized by left and/or right ventricular hypertrophy (HYPERTROPHY, LEFT VENTRICULAR; HYPERTROPHY, RIGHT VENTRICULAR), frequent asymmetrical involvement of the HEART SEPTUM, and normal or reduced left ventricular volume. Risk factors include HYPERTENSION; AORTIC STENOSIS; and gene MUTATION; (FAMILIAL HYPERTROPHIC CARDIOMYOPATHY).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with bisoprolol was well-tolerated and effective in relieving obstruction and improving symptoms in a significant proportion of patients with symptomatic obstructive HCM." | 1.72 | Bisoprolol for treatment of symptomatic patients with obstructive hypertrophic cardiomyopathy. The BASIC (bisoprolol AS therapy in hypertrophic cardiomyopathy) study. ( Caiazza, M; Calabrò, P; Cirillo, A; Dongiglio, F; Franco, F; Fusco, A; Limongelli, G; Lioncino, M; Mazzella, M; Monda, E; Moscarella, E; Pacileo, G; Palmiero, G; Rubino, M; Sepe, J; Verrillo, F, 2022) |
| "Left ventricular hypertrophy was diagnosed using the Sokolow-Lyon indices." | 1.48 | Left ventricular hypertrophy diagnosed after a stroke: a case report. ( Kanyal, R; Umeojiako, WI, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 7 (63.64) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Monda, E | 1 |
| Lioncino, M | 1 |
| Palmiero, G | 1 |
| Franco, F | 1 |
| Rubino, M | 1 |
| Cirillo, A | 1 |
| Verrillo, F | 1 |
| Fusco, A | 1 |
| Caiazza, M | 1 |
| Mazzella, M | 1 |
| Moscarella, E | 1 |
| Dongiglio, F | 1 |
| Sepe, J | 1 |
| Pacileo, G | 1 |
| Calabrò, P | 1 |
| Limongelli, G | 1 |
| Imori, Y | 1 |
| Takano, H | 1 |
| Mase, H | 1 |
| Matsuda, J | 1 |
| Sangen, H | 1 |
| Izumi, Y | 1 |
| Tokita, Y | 1 |
| Yamamoto, T | 1 |
| Shimizu, W | 1 |
| Prajapati, C | 1 |
| Ojala, M | 1 |
| Aalto-Setälä, K | 1 |
| Umeojiako, WI | 1 |
| Kanyal, R | 1 |
| Tezuka, A | 1 |
| Higo, K | 1 |
| Nakamukae, Y | 1 |
| Nishihara, S | 1 |
| Kamikawa, M | 1 |
| Shimofuku, C | 1 |
| Kawazoe, K | 1 |
| Ohishi, M | 1 |
| Minami, Y | 1 |
| Hagiwara, N | 1 |
| Olivotto, I | 2 |
| Cecchi, F | 2 |
| Bini, R | 1 |
| Favilli, S | 1 |
| Murzi, B | 1 |
| El-Hamamsy, I | 1 |
| Yacoub, MH | 1 |
| Nistri, S | 1 |
| Maron, MS | 1 |
| Ferrantini, C | 1 |
| Coppini, R | 1 |
| Grifoni, C | 1 |
| Baldini, K | 1 |
| Sgalambro, A | 1 |
| Maron, BJ | 1 |
| Katarzynska-Szymanska, A | 1 |
| Ochotny, R | 1 |
| Oko-Sarnowska, Z | 1 |
| Wachowiak-Baszynska, H | 1 |
| Krauze, T | 1 |
| Piskorski, J | 1 |
| Gwizdala, A | 1 |
| Mitkowski, P | 1 |
| Guzik, P | 1 |
| Cabrera-Bueno, F | 1 |
| García-Pinilla, JM | 1 |
| Gómez-Doblas, JJ | 1 |
| Montiel-Trujillo, A | 1 |
| Rodríguez-Bailón, I | 1 |
| de Teresa-Galván, E | 1 |
| Kondo, I | 1 |
| Mizushige, K | 1 |
| Nozaki, S | 1 |
| Iwado, Y | 1 |
| Masugata, H | 1 |
| Kohno, M | 1 |
| Matsuo, H | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effect of Metoprolol in Post Alcohol Septal Ablation Patients With Hypertrophic Cardiomyopathy[NCT04133532] | Phase 4 | 22 participants (Actual) | Interventional | 2020-03-05 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for bisoprolol and Cardiomyopathy, Hypertrophic
| Article | Year |
|---|---|
Beta-blocker therapy for dynamic left ventricular outflow tract obstruction induced by exercise.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Bisoprolol; Cardiomyopathy, Hypertrophic; Echocardiogr | 2007 |
10 other studies available for bisoprolol and Cardiomyopathy, Hypertrophic
| Article | Year |
|---|---|
Bisoprolol for treatment of symptomatic patients with obstructive hypertrophic cardiomyopathy. The BASIC (bisoprolol AS therapy in hypertrophic cardiomyopathy) study.
Topics: Adult; Bisoprolol; Cardiomyopathy, Hypertrophic; Disopyramide; Humans; Retrospective Studies; Ventri | 2022 |
Bisoprolol transdermal patch for perioperative care of non-cardiac surgery in patients with hypertrophic obstructive cardiomyopathy.
Topics: Administration, Cutaneous; Administration, Oral; Adrenergic beta-1 Receptor Antagonists; Bisoprolol; | 2019 |
Divergent effects of adrenaline in human induced pluripotent stem cell-derived cardiomyocytes obtained from hypertrophic cardiomyopathy.
Topics: Action Potentials; Arrhythmias, Cardiac; Bisoprolol; Cardiomyopathy, Hypertrophic; Epinephrine; Hear | 2018 |
Left ventricular hypertrophy diagnosed after a stroke: a case report.
Topics: Aged, 80 and over; Antihypertensive Agents; Bisoprolol; Cardiomyopathy, Hypertrophic; Chest Pain; Co | 2018 |
Bisoprolol Successfully Improved the Intraventricular Pressure Gradient in a Patient with Midventricular Obstructive Hypertrophic Cardiomyopathy with an Apex Aneurysm due to Apical Myocardial Damage.
Topics: Aged, 80 and over; Anticoagulants; Bisoprolol; Cardiomyopathy, Hypertrophic; Heart Aneurysm; Humans; | 2019 |
Pharmacological Strategies for Midventricular Obstruction in Patients with Hypertrophic Cardiomyopathy.
Topics: Aneurysm; Bisoprolol; Cardiomyopathy, Hypertrophic; Humans; Ventricular Outflow Obstruction; Ventric | 2019 |
Tunneled left anterior descending artery in a child with hypertrophic cardiomyopathy.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Bisoprolol; Cardiac Surgical Procedures; Cardiomyopath | 2009 |
β Blockers for prevention of exercise-induced left ventricular outflow tract obstruction in patients with hypertrophic cardiomyopathy.
Topics: Adrenergic beta-Antagonists; Adult; Bisoprolol; Cardiomyopathy, Hypertrophic; Cohort Studies; Confid | 2012 |
Shortening baroreflex delay in hypertrophic cardiomyopathy patients -- an unknown effect of β-blockers.
Topics: Adolescent; Adrenergic beta-1 Receptor Antagonists; Adult; Aged; Baroreflex; Bisoprolol; Cardiomyopa | 2013 |
Effect of cibenzoline, a class ia antiarrhythmic agent, on left ventricular diastolic function in hypertrophic cardiomyopathy.
Topics: Administration, Oral; Aged; Anti-Arrhythmia Agents; Bisoprolol; Blood Flow Velocity; Cardiomyopathy, | 2001 |